Learn More
Medchemexpress LLC Miglustat hydrochloride | 210110-90-0 | 98.0% | 255.74 | 50 MG

Supplier: Medchemexpress LLC HY17020A50MG
Miglustat (N-Butyldeoxynojirimycin) hydrochloride is an orally active and reversible ceramide glucosyltransferase inhibitor, with blood-brain barrier permeability. It can be used for the research of type I gaucher disease.
- Orally active and reversible ceramide glucosyltransferase inhibitor
- Blood-brain barrier permeability
- Used for research of type I Gaucher disease
- Restores F508del-CFTR function in cystic fibrosis (CF) bronchial epithelial IB3-1 and CuFi-1 cells
- Reduces inflammatory response to P. aeruginosa in both CF and non-CF bronchial cells
- Able to rescue synaptic plasticity deficits, to restore ERKs activation and to counteract hyperexcitability in NPC1-/- mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.